Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants

Cancer Research

Volumn 74, Issue 6, 2014, Pages 1670-1681

  Ali, Omar A ^a   Verbeke, Catia ^a   Johnson, Chris ^a   Sands, R Warren ^a   Lewin, Sarah A ^a   White, Des ^a   Doherty, Edward ^a   Dranoff, Glenn ^b,c   Mooney, David J ^a  

^a HARVARD UNIVERSITY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; PHOSPHORYL LIPID A; POLYGLACTIN; POLYINOSINIC POLYCYTIDYLIC ACID; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER PREVENTION; CD8+ DENDRITIC CELL; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG RELEASE; FEMALE; IMMUNE RESPONSE; IMMUNOREGULATION; LONG TERM SURVIVAL; MELANOMA CELL; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; TUMOR IMMUNITY; TUMOR REGRESSION; VACCINE PRODUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CANCER VACCINES; CELL LINE, TUMOR; DELAYED-ACTION PREPARATIONS; DENDRITIC CELLS; DRUG CARRIERS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN-12; LIPID A; MELANOMA, EXPERIMENTAL; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; OLIGODEOXYRIBONUCLEOTIDES; POLY I-C; POLYGLACTIN 910; T-LYMPHOCYTES, CYTOTOXIC; TOLL-LIKE RECEPTORS;

EID: 84896523011     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-0777     Document Type: Article

References (47)

1. Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001;106:263-6. (Pubitemid 32772609)
2. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52. (Pubitemid 28155090)
3. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001;106:255-8. (Pubitemid 32772607)
4. Sansonetti PJ. The innate signaling of dangers and the dangers of innate signaling. Nat Immunol 2006;7:1237-42. (Pubitemid 46111240)
5. Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature 2006;442:39-44. (Pubitemid 44064203)
6. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801. (Pubitemid 43261452)
7. Gilboa E. Dendritic cell based vaccines. J Clin Invest 2007;117: 1195-203.
8. Banchereau J, Steinman RM. Taking dendritic cells into medicine. Nature 2007;49:419-26. (Pubitemid 47509552)
9. Naik SH, Sathe P, Park HY, Metcalf D, Proietto AI, Dakic A, et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat Immunol 2007;8:1217-26. (Pubitemid 350011760)
10. O'Garra1 A, Trinchieri G. Are dendritic cells afraid of commitment? Nat Immunol 2004;5:1206-8.
11. D'Amico A, Wu L. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J Exp Med 2003;2:293-303. (Pubitemid 36987854)
12. Villadangos JA, Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 2007;7:543-55. (Pubitemid 46987783)
13. Liu YJ. Dendritic cell subsets and lineages and their functions in innate and adaptive immunity. Cell 2001;106:259-62.
14. Jego G, Palucka KA, Blank JP, Chalouni P, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferoun and interleukin 6. Immunity 2003;19:225-34. (Pubitemid 37011337)
15. Randolph GJ, Ochando J, Partida-Sanchez S. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol 2008;26: 293-316. (Pubitemid 351600378)
16. Schnorrer P. The dominant role of CD8+ dendritic cells in crosspresentation is not dictated by antigen capture. Proc Natl Acad Sci U S A 2006;28:10729-34. (Pubitemid 44078044)
17. Skokos D, Nussenzweig MC. CD8 DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. J Exp Med 2007;204:1525-31. (Pubitemid 47048020)
18. Den Haana JM, Lehara SM, Bevan MJ. CD8+ but not CD8 dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 2000;12: 1685-96.
19. Moser M, Murphy KM. Dendritic cell regulation of TH1-TH2 development. Nat Immunol 2000;1:199-205.
20. Hildner K, Edelson BT, PurthaWE, Diamond M, Matsushita H, Kohyama M, et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 2008;322:1097-100.
21. Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 2007;13:552-9. (Pubitemid 46830615)
22. Hansen M, Hjortø GM, Donia M, Met O, Larsen NB, Andersen MH, et al. Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy. Vaccine 2013;31:639-46.
23. Schuler G, Schuler-Thurner B, Steinman RM. The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 2003;15:138-47. (Pubitemid 36287518)
24. Curiel TJ, Curiel DT. Tumor immunotherapy: inching toward the finish line. J Clin Invest 2002;109:311-2. (Pubitemid 34141803)
25. Ali OA, Huebsch N, Cao L, Dranoff G, Mooney DJ. Infection mimicking materials to program dendritic cells in situ. Nat Mater 2009;2:151-8.
26. Ali OA, Emerich D, Dranoff G, Mooney DJ. In situ regulation of DC subsets and T Cells mediates tumor regression in mice. Sci Transl Med 2009;1:8-19.
27. Harris LD, Kim BS, Mooney DJ. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res 1998;42:396-402. (Pubitemid 28452514)
28. Cohen S, Yoshioka T, Lucarelli M, Hwang LH, Langer R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res 1991;8:713-20.
29. Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martínez- Llordella M, Ashby M, et al. Instability of the transcriptionfactor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009;10:1000-7.
30. Huang YC, Connell M, Park Y, Mooney DJ, Rice KG. Fabrication and in vitro testing of polymeric delivery system for condensed DNA. J Biomed Mater Res A 2003;67:1384-92. (Pubitemid 37522753)
31. Houchin ML, Topp EM. Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms. J Pharm Sci 2008;97:2395-404.
32. Thomas WR, Edwards AJ, Watkins MC, Asherson GL. Distribution of immunogenic cells after painting with the contact sensitizers fluorescein isothiocyanate and oxazolone. Different sensitizers form immunogenic complexes with different cell populations. Immunology 1980;39:21-7.
33. Hodge-Dufour J, Marino MW, Horton MR, Jungbluth A, Burdick MD, Strieter RM, et al. Inhibition of interferon g induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc Natl Acad Sci U S A 1998;95:13806-11. (Pubitemid 28523054)
34. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004; 16:3-9. (Pubitemid 38147427)
35. Yun PL, DeCarlo AA, Collyer C, Hunter N. Modulation of an interleukin-12 and gamma interferon synergistic feedback regulatory cycle of Tcell and monocyte cocultures by Porphyromonas gingivalis lipopolysaccharide in the absence or presence of cysteine proteinases. Infect Immun 2002;70:5695-705.
36. Hailemichael Y, Dai Z, Jaffarzad N, Ye Y, Medina MA, Huang XF, et al. Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion. Nat Med 2013; 19:465-72.
37. Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004;10:909-15. (Pubitemid 39273730)
38. Klebanoff CA, Gattinoni L, Restifo NP. CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev 2006;211:214-24. (Pubitemid 43882974)
39. Quezada SA, Peggs KS, Curran MA, Allison JP. CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. J Clin Invest 2006;116: 1935-45. (Pubitemid 44033317)
40. Hodi FS, Butler M, Oble DA, Seiden MV, Haluska FG, Kruse A, et al. Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-Associated antigen 4 in previously vaccinated cancer patients. Proc Natl Acad Sci U S A 2008;105:3005-10. (Pubitemid 351723658)
41. Wei G, Wei L, Zhu J, Zang C, Hu-Li J, Yao Z, et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009;30: 155-67.
42. Oldenhove G, Bouladoux N, Wohlfert EA, Hall JA, Chou D, Dos Santos L, et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 2009;31: 772-86.
43. Kitabayashi A, Hirokawa M, Hatano Y, Lee M, Kuroki J, Niitsu H, et al. Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor a production. Blood 1995;86:2220-7.
44. Rutella S, Rumi C, Lucia MB, Sica S, Cauda R, Leone G. Serum of healthy donors receiving granulocyte colony stimulating factor induces T cell unresponsiveness. Exp Hematol 1998;26: 1024-33. (Pubitemid 28477769)
45. Mielcarek M, Graf L, Johnson G, Torok-Storb B. Production of interleukin-10 by granulocyte colony stimulating factor mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. Blood 1998;92:215-22. (Pubitemid 28303195)
46. Pulendran B, Banchereau J, Burkeholder S, Kraus E, Guinet E, Chalouni C, et al. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol 2000;165:566-72. (Pubitemid 30429552)
47. Greter M, Helft J, Chow A, Hashimoto D, Mortha A, Agudo-Cantero J, et al. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity 2012;36:1031-46.